World Molecular Imaging Congress 2017: IMAGinING the Future: from Molecules to Medicine

摘要 分子成像（MI）在理解、检测和诊断中找到了变革性的应用。 治疗几乎所有的人类疾病。多元智能领域代表了多种科学 领域，包括成像技术，分子生物学和化学，这是提供主要 科学界的新见解和进步。世界分子影像学会 （WMIS）体现了MI领域作为一个致力于发展和促进 在原子水平上的各种类型的临床前和临床成像，以了解和有效地 治疗各种专业的经常危及生命的疾病，例如肿瘤学，传染病 疾病学、神经病学、心脏病学、风湿病学和内分泌学。的一个显著特点 我们的社会是高度集成的，多模式的方法，从科学创新， 在诊所里照顾病人。作为一个国际性的科学教育组织， 包括基础和转化科学家，临床医生，年轻的研究人员和学生 来自各种学科，有一个专门的共同目标，以了解生物学 和医学，通过对涉及的细胞和分子事件进行多模式体内成像， 正常和病理过程以及定量MI在患者护理中的应用。年度 世界分子影像大会（WMIC）为WMIS会员和非会员举办 感兴趣的领域，谁来自学术界和工业界，是唯一的 一个全面的国际会议。事实上，WMIC是MI的缩影， 为具有不同背景的科学家和临床医生提供了一个平台， 讨论和跟踪前沿进展妇女管理信息系统正在积极寻求各种机制， 保持这一多学科变革领域的动力和快速发展轨迹， 特别是通过为博士后研究员和研究生提供旅费。这些 个人将在决定如何在医疗保健中使用MI方面发挥未来的作用。R13的目标是 是获得特定的资金，以支付费用，支持学生在研究生入学 和博士后水平，特别是鼓励妇女，代表性不足的少数民族， 残疾人，使他们能够参加一年一度的世界医学大会，明年， 费城，宾夕法尼亚州，2017年9月13日至16日。

ABSTRACT Molecular imaging (MI) is finding transformative applications in the understanding, detection and treatment of nearly all human diseases. The field of MI represents a fusion of diverse scientific fields, including imaging technologies, molecular biology, and chemistry, that is providing major new insights and advances to the scientific community. The World Molecular Imaging Society (WMIS) embodies the field of MI as an organization dedicated to developing and promoting preclinical and clinical imaging of various types at the atomic level, to understand and effectively treat often life-threatening diseases of a variety of specialties, such as in oncology, infectious disease, neurology, cardiology, rheumatology, and endocrinology. A distinguishing feature of our society is the highly-integrated, multimodal approach that spans from scientific innovation to patient care in the clinic. As an international scientific educational organization, active members of WMIS include basic and translational scientists, clinicians, young researchers and students from a wide variety of disciplines, with a dedicated common goal to the understanding of biology and medicine through multimodal in vivo imaging of cellular and molecular events involved in normal and pathologic processes and utilization of quantitative MI in patient care. The annual World Molecular Imaging Congress (WMIC) is held for WMIS members and non-members interested in the field, who come from both academics and industry, and is the only comprehensive, international meeting of MI. Indeed, the WMIC is the epitome of MI that provides a platform for scientists and clinicians with diverse backgrounds to interact, present, and discuss and follow cutting-edge advances. The WMIS is actively seeking mechanisms to maintain the impetus and rapid trajectories of this multidisciplinary transformative field, in particular, by securing travel funds for post-doctoral fellows and graduate students. These individuals will play future roles in deciding how MI is utilized in healthcare. The goal of this R13 is to obtain specific funds to cover costs that support the attendance of students at the graduate and postdoctoral levels, especially encouraging women, underrepresented minorities and persons with disabilities, enabling their attendance to the annual WMIC, next year in Philadelphia, Pennsylvania on September 13-16, 2017.